ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 608,66
0,31%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Palatin Technologies Inc New (PTN)

  7. Palatin Technologies Inc New (PTN) Actualités

PTN

Palatin Technologies (PTN)

Palatin Technologies Inc New
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:PTN
DateHeureSourceTitreSymboleSociété
08/04/202413h30PR Newswire (US)Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024AMEX:PTNPalatin Technologies Inc New
07/03/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
04/03/202418h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
28/02/202413h30PR Newswire (US)Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)AMEX:PTNPalatin Technologies Inc New
15/02/202415h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
15/02/202413h30PR Newswire (US)Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
14/02/202422h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PTNPalatin Technologies Inc New
14/02/202420h55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PTNPalatin Technologies Inc New
09/02/202413h30PR Newswire (US)Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024AMEX:PTNPalatin Technologies Inc New
05/02/202413h30PR Newswire (US)Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)AMEX:PTNPalatin Technologies Inc New
01/02/202422h00PR Newswire (US)Palatin Announces Closing of $10 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
01/02/202415h40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:PTNPalatin Technologies Inc New
30/01/202414h00PR Newswire (US)Palatin Announces $10 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
08/01/202416h33PR Newswire (US)Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024AMEX:PTNPalatin Technologies Inc New
03/01/202414h00Business WireCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.AMEX:PTNPalatin Technologies Inc New
20/12/202313h30PR Newswire (US)Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 MillionAMEX:PTNPalatin Technologies Inc New
18/12/202322h15PR Newswire (US)Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE AmericanAMEX:PTNPalatin Technologies Inc New
18/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:PTNPalatin Technologies Inc New
15/12/202322h03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PTNPalatin Technologies Inc New
04/12/202323h00Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:PTNPalatin Technologies Inc New
14/11/202313h30PR Newswire (US)Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
09/11/202313h30PR Newswire (US)Palatin to Report First Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on November 14, 2023AMEX:PTNPalatin Technologies Inc New
24/10/202322h50PR Newswire (US)Palatin Announces Closing of $5 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
23/10/202313h30PR Newswire (US)Palatin Announces $5 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
19/10/202313h30PR Newswire (US)Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue ResultsAMEX:PTNPalatin Technologies Inc New
18/10/202313h30PR Newswire (US)Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss; Initiating Clinical Study of Melanocortin 4 Receptor Agonist + GLP-1 in Obese PatientsAMEX:PTNPalatin Technologies Inc New
16/10/202313h30PR Newswire (US)Palatin Presents Data at the United European Gastroenterology Week 2023 Conference On PL8177 Ulcerative Colitis TreatmentAMEX:PTNPalatin Technologies Inc New
13/10/202322h15PR Newswire (US)Palatin Receives Notice of Non-Compliance from NYSE AmericanAMEX:PTNPalatin Technologies Inc New
28/09/202314h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:PTNPalatin Technologies Inc New
28/09/202313h30PR Newswire (US)Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
 Showing the most relevant articles for your search:AMEX:PTN

Dernières Valeurs Consultées

EU
BEL20
Bel 20
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
EU
MC
Lvmh Moet Hennessy Louis...
EU
GLE
Societe Generale
EU
VIV
Vivendi
EU
ML
Michelin
EU
CS
Axa
EU
EN
Bouygues
EU
DG
Vinci
EU
RI
Pernod Ricard
NYSE
JPM
JP Morgan Chase
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés